Ownership history in UBS Group AG · 8 quarters on record
This page tracks every 13F SEC filing in which UBS Group AG reported a position in PAVMED INC (PAVM). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | ADDED | 219,813 | +218,944 | +25194.9% | 0.00% | $49K | $6.63 |
| 2025 Q3 | REDUCED | 869 | -7,882 | -90.1% | 0.00% | $375 | $12.93 |
| 2025 Q2 | ADDED | 8,751 | +7,592 | +655.0% | 0.00% | $5K | $18.00 |
| 2025 Q1 | REDUCED | 1,159 | -11,628 | -90.9% | 0.00% | $835 | $21.63 |
| 2024 Q4 | ADDED | 12,787 | +12,778 | +141977.8% | 0.00% | $8K | $18.84 |
| 2024 Q3 | REDUCED | 9 | -4,786 | -99.8% | 0.00% | $11 | $36.90 |
| 2024 Q2 | REDUCED | 4,795 | -1,222 | -20.3% | 0.00% | $4K | $24.45 |
| 2023 Q4 | INITIATED | 6,017 | — | — | 0.00% | $25K | — |
As of 2025 Q4 — sorted by position size